These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24636176)

  • 1. Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum.
    Myśliwiec M; Walczak M; Małecka-Tendera E; Dobrzańska A; Cybulska B; Filipiak K; Mazur A; Jarosz-Chobot P; Szadkowska A; Rynkiewicz A; Chybicka A; Socha P; Brandt A; Bautembach-Minkowska J; Zdrojewski T; Limon J; Gidding SS; Banach M
    J Clin Lipidol; 2014; 8(2):173-80. PubMed ID: 24636176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak K; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    J Clin Lipidol; 2013; 7(3):217-21. PubMed ID: 23725921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in the Management of Pediatric Dyslipidemia.
    Ross JL
    J Pediatr Nurs; 2016; 31(6):723-735. PubMed ID: 27496827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
    Saltijeral A; Pérez de Isla L; Alonso R; Muñiz O; Díaz-Díaz JL; Fuentes F; Mata N; de Andrés R; Díaz-Soto G; Pastor J; Pinilla JM; Zambón D; Pinto X; Badimón L; Mata P;
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):444-450. PubMed ID: 27913073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
    Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
    Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
    Tada H; Takamura M; Kawashiri MA
    Vasc Health Risk Manag; 2021; 17():59-67. PubMed ID: 33628029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypercholesterolaemia: a model of care for Australasia.
    Watts GF; Sullivan DR; Poplawski N; van Bockxmeer F; Hamilton-Craig I; Clifton PM; O'Brien R; Bishop W; George P; Barter PJ; Bates T; Burnett JR; Coakley J; Davidson P; Emery J; Martin A; Farid W; Freeman L; Geelhoed E; Juniper A; Kidd A; Kostner K; Krass I; Livingston M; Maxwell S; O'Leary P; Owaimrin A; Redgrave TG; Reid N; Southwell L; Suthers G; Tonkin A; Towler S; Trent R;
    Atheroscler Suppl; 2011 Oct; 12(2):221-63. PubMed ID: 21917530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J
    Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
    Elis A; Zhou R; Stein EA
    Am J Cardiol; 2011 Jul; 108(2):223-6. PubMed ID: 21545982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JCL roundtable: drug treatment of severe forms of familial hypercholesterolemia.
    Brown WV; Rader DJ; Goldberg AC
    J Clin Lipidol; 2014; 8(1):10-7. PubMed ID: 24528683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.
    Narverud I; Retterstøl K; Iversen PO; Halvorsen B; Ueland T; Ulven SM; Ose L; Aukrust P; Veierød MB; Holven KB
    Atherosclerosis; 2014 Aug; 235(2):299-309. PubMed ID: 24908240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia in childhood and adolescents: A hidden reality.
    Plana N; Rodríguez-Borjabad C; Ibarretxe D; Masana L
    Clin Investig Arterioscler; 2017; 29(3):129-140. PubMed ID: 28390853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.
    Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL
    Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.
    Turgeon RD; Barry AR; Pearson GJ
    Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.